Botanix Investor Centre

Botanix is an ASX-listed company (ASX:BOT), in a prime position for growth and to return value for shareholders. With deep expertise in dermatology and pharmaceutical product commercialisation, we are on track to disrupt some of the most lucrative global healthcare markets.

ASX: BOT | Share price


18 June 2019 – The Green Fund – Report
06 April 2017 – Under The Radar

Share Registry

Our share and options registers are maintained by Automic Group (Automic).

Security holders who wish to update personal or contact information, elect to receive communications electronically, such as the company’s annual report or notice of meeting, or provide banking details can do so via the Automic website here and follow the prompts, or contact Automic (using the details below).

When updating information electronically or contacting Automic you will need your Security Reference Number (SRN) or your Holder Identification Number (HIN) and your postcode. Both numbers are on your Issuer Sponsored/CHESS statements.

The share registry’s contact details are:

p: 1300 288 664 (within Australia) +61 (0)2 9698 5414 (Overseas)

6 February 2024
8 November 2023
12 July 2022
December 9, 2019
September 17, 2019
January 31, 2019
November 15, 2018
August 13, 2018
April 9, 2018
November 13, 2017

Latest video

Final Sofdra™ Labelling Discussions with FDA

Botanix has submitted the last label materials to the US Food…

“Compelling Opportunity” | E&P Research Report

In new research on Botanix, leading biotech analyst David Nayagam…

Euroz Hartleys Analysis | Commercial Day Webinar

Euroz Hartleys’ Seth Lizee reviews the Botanix Commercial…

Video Available | Commercial Day Webinar

Video is now available of the Company’s Commercial Day Webinar…

Botanix Included in the All Ordinaries Index

Botanix Pharmaceuticals (ASX:BOT) is honoured to announce the…

Botanix appoints Graeme Morissey CFO

Botanix Pharmaceuticals (ASX:BOT) is pleased to announce the…

Botanix to Present at Euroz Hartleys Institutional Conference

Botanix Pharmaceuticals (ASX:BOT) announced that Botanix CEO…

Check out our latest investor presentation

Sign up to receive our latest news

Thank you! Your subscription has been confirmed. You'll hear from us soon.